IRON
Price
$81.84
Change
+$2.13 (+2.67%)
Updated
Feb 4, 04:59 PM (EDT)
Capitalization
3.01B
51 days until earnings call
Intraday BUY SELL Signals
RPRX
Price
$43.61
Change
+$0.64 (+1.49%)
Updated
Feb 4, 03:15 PM (EDT)
Capitalization
18.36B
7 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IRON vs RPRX

Header iconIRON vs RPRX Comparison
Open Charts IRON vs RPRXBanner chart's image
Disc Medicine
Price$81.84
Change+$2.13 (+2.67%)
Volume$33.31K
Capitalization3.01B
Royalty Pharma
Price$43.61
Change+$0.64 (+1.49%)
Volume$4.25K
Capitalization18.36B
IRON vs RPRX Comparison Chart in %
IRON
Daily Signal:
Gain/Loss:
RPRX
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
IRON vs. RPRX commentary
Feb 05, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IRON is a Buy and RPRX is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Feb 05, 2026
Stock price -- (IRON: $79.71 vs. RPRX: $42.97)
Brand notoriety: IRON and RPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IRON: 42% vs. RPRX: 85%
Market capitalization -- IRON: $3.01B vs. RPRX: $18.36B
IRON [@Biotechnology] is valued at $3.01B. RPRX’s [@Biotechnology] market capitalization is $18.36B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.13B to $0. The average market capitalization across the [@Biotechnology] industry is $2.23B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IRON’s FA Score shows that 0 FA rating(s) are green whileRPRX’s FA Score has 2 green FA rating(s).

  • IRON’s FA Score: 0 green, 5 red.
  • RPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, RPRX is a better buy in the long-term than IRON.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IRON’s TA Score shows that 5 TA indicator(s) are bullish while RPRX’s TA Score has 5 bullish TA indicator(s).

  • IRON’s TA Score: 5 bullish, 3 bearish.
  • RPRX’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, IRON is a better buy in the short-term than RPRX.

Price Growth

IRON (@Biotechnology) experienced а -2.96% price change this week, while RPRX (@Biotechnology) price change was +5.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -2.56%. For the same industry, the average monthly price growth was +1.40%, and the average quarterly price growth was +33.10%.

Reported Earning Dates

IRON is expected to report earnings on Mar 27, 2026.

RPRX is expected to report earnings on Feb 11, 2026.

Industries' Descriptions

@Biotechnology (-2.56% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RPRX($18.4B) has a higher market cap than IRON($3.01B). RPRX YTD gains are higher at: 11.206 vs. IRON (0.378). RPRX has higher annual earnings (EBITDA): 1.59B vs. IRON (-177.16M). RPRX has more cash in the bank: 1.82B vs. IRON (616M). IRON has less debt than RPRX: IRON (31M) vs RPRX (8.95B). RPRX has higher revenues than IRON: RPRX (2.35B) vs IRON (0).
IRONRPRXIRON / RPRX
Capitalization3.01B18.4B16%
EBITDA-177.16M1.59B-11%
Gain YTD0.37811.2063%
P/E RatioN/A24.55-
Revenue02.35B-
Total Cash616M1.82B34%
Total Debt31M8.95B0%
FUNDAMENTALS RATINGS
RPRX: Fundamental Ratings
RPRX
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
2
Undervalued
PROFIT vs RISK RATING
1..100
99
SMR RATING
1..100
95
PRICE GROWTH RATING
1..100
46
P/E GROWTH RATING
1..100
9
SEASONALITY SCORE
1..100
64

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IRONRPRX
RSI
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
58%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
67%
Bearish Trend 2 days ago
57%
Momentum
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
45%
MACD
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
47%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
81%
Bullish Trend 2 days ago
48%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
48%
Advances
ODDS (%)
Bullish Trend 9 days ago
84%
Bullish Trend 2 days ago
51%
Declines
ODDS (%)
Bearish Trend 6 days ago
82%
Bearish Trend 16 days ago
60%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
59%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
62%
View a ticker or compare two or three
Interact to see
Advertisement
IRON
Daily Signal:
Gain/Loss:
RPRX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MINIX50.220.08
+0.16%
MFS International Intrinsic Value I
PNVAX45.84-0.08
-0.17%
Putnam International Small Cap A
RSINX17.09-0.04
-0.23%
Victory RS Investors A
WSGAX12.17-0.05
-0.41%
Nomura Small Cap Growth A
JSEPX33.26-0.20
-0.60%
JPMorgan Small Cap Equity R3

IRON and

Correlation & Price change

A.I.dvisor indicates that over the last year, IRON has been loosely correlated with SYRE. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if IRON jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRON
1D Price
Change %
IRON100%
-1.17%
SYRE - IRON
54%
Loosely correlated
+1.65%
NCEL - IRON
54%
Loosely correlated
-0.73%
XNCR - IRON
52%
Loosely correlated
-0.99%
CGON - IRON
51%
Loosely correlated
-3.28%
IDYA - IRON
51%
Loosely correlated
+0.50%
More

RPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with AXON. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+1.44%
AXON - RPRX
48%
Loosely correlated
-1.89%
IRON - RPRX
33%
Poorly correlated
-1.17%
MDGL - RPRX
31%
Poorly correlated
-1.49%
TECH - RPRX
31%
Poorly correlated
-0.95%
HALO - RPRX
31%
Poorly correlated
+2.73%
More